Bristol-myers Squibb Recent News
Benzinga's Bulls & Bears Of The Week: Bristol-Myers, GE, Target, Under Armour And More
Ahead Of Earnings: Why You Should Be Buying Merck And Selling Bristol-Myers
Barron's Picks And Pans: Bristol-Myers, Texas Instruments, Altaba And More
Short Sellers Pile On Pfizer After Buyout Rumors
Biotech In The Earnings Spotlight: Amgen, Celgene, Gilead Sciences
Big Biotech In The Earnings Spotlight
Barron's: Are Trump And Sanders Killing The Market?
Barron's Picks And Pans: Bristol-Myers Squibb, KeyCorp, Core-Mark And More
Credit Suisse: We Prefer Pfizer, Bristol Over Pharma Peers
With Bristol-Myers Trial Stopped Early, 'What's Next?'
Bristol-Myers Up Big After Drug Study Stopped Early
Bristol-Myers Squibb Is Re-Testing Its Breakout Level
5 Companies That Could Develop An Enterovirus Treatment
Markets Little Changed In Low Volume And Slow News Ahead Of Long Weekend
Markets Marginally Higher On Light Volume And Encouraging Geopolitical Developments
Dow Sets New Intraday High; Citigroup Impresses With Earnings
Earnings Expectations For The Week Of April 28: Big Oil, Big Pharma And More
Market Wrap For February 25: Markets End The Day Relatively Flat
Earnings Expectations For The Week Of January 20: Microsoft, McDonald's, Netflix And More
Market Wrap For December 20: Markets Gain On GDP Data
Market Wrap For December 18: Markets Flat During Day One Post Fed Taper
Earnings Expectations For The Week Of October 21: The Crunch Is On
Short Sellers Move On Amgen, Vertex (AMGN, PCYC, VRTX)